Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

What's hot

Work With Us
Invest With Us

#pharmeasy

PharmEasy valuation 2024, PharmEasy financial struggles, Janus Henderson PharmEasy, API Holdings losses, PharmEasy IPO plans, healthtech valuation drop, Thyrocare acquisition, Indian startup funding

PharmEasy’s Valuation Drops to $456 Million Amid Financial Challenges

Saral GroupsDecember 28, 2024
Introduction to PharmEasy’s Valuation Decline PharmEasy, once valued at $5.6 billion, has seen its valuation drop drastically to $456 million. The decline, revealed by investor Janus Henderson, underscores the challenges faced by the Indian healthtech company. Key Insights from the Report Janus Henderson’s Valuation Update This represents a 92% drop from PharmEasy’s peak valuation of...
Read more

Must Read

Popular Posts

Book Free Consultation


Get in Touch

  • +91 11692 72696
  • builders@saralgroups.com
  • Office Address 1: 393, Main Gali, Shiv Nagar, Panipat, India, 132103
  • Office Address 2: 605, Gandhi Market, New Delhi, India, 110002
  • Office Address 3: 49A, Kudlu Gate, HSR Layout, Bengaluru, India 560114
Linkedin Facebook Instagram Whatsapp Youtube

Most popular

B2B

Fashion

Gaming

Health

Lifestyle

Social Media

Sustainability

Technology

Travel

Women in Leadership

Links

Popular Tags

#apple #ather #blinkit #electric #godrej #jammu #leadership #nazaratech #ola #pharmeasy #PhysicsWallah #Razorpay #RBI #SEBI #zunroof $100B valuation $14.2M building purchase $300 $50M Series A $63 million funding 000 grant 2025 Gaming News 409A valuations A/B testing Accessibility in Communication Accessibility Projects Punjab accessible healthcare ad-free search adaptability aerospace innovation India

Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

Trending News

Disclaimer:
1. We are not SEBI registered. The investment advice or any information provided by us is for education purposes only. We will not be responsible for any of your profit/loss with any channel suggestions. We recommend you to consult your financial advisor before taking any financial decisions.
2. We always strive for accuracy providing support with our best capabilities, but we acknowledge that sometime some content may have some inaccuracies or contains false informations, and we encourage you to inform us of any errors you find so we can make improvements. For queries, contact our email support at contact@saralgroups.com or tel: +91 11692 72696.

Copyright © 2025 SGELITE PRIVATE LIMITED. All rights reserved.